Press Release Archive

December 24, 2020

EOM PHARMACEUTICALS ANNOUNCES ITS PRE-IND MEETING REQUEST WITH U.S. FDA TO EVALUATE PLANS FOR A PHASE 2 CLINICAL TRIAL OF ITS INVESTIGATIONAL DUAL-ACTING, BROAD-SPECTRUM IMMUNOMODULATOR IN COVID-19 PATIENTS

DOWNLOAD

December 17, 2020

EOM PHARMACEUTICALS APPOINTS BUSINESS VETERAN WAYNE I. DANSON AS CHIEF FINANCIAL OFFICER AND TREASURER

DOWNLOAD